Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5776834

CN1CCN(C(=O)CCc2cnoc2-c2ccc(F)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
POLB P06746 1/20 0.45
HDAC4 P56524 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
KDM1A O60341 1/20 0.39
MAOB P27338 1/20 0.39
GFER P55789 1/20 0.39
CCNC P24863 1/20 0.38
CDK8 P49336 1/20 0.38
DPP8 Q6V1X1 2/20 0.37
DPP7 Q9UHL4 2/20 0.37
CACNA1F O60840 1/20 0.37
HTR1A P08908 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
DRD4 P21917 1/20 0.37
DRD5 P21918 1/20 0.37
HRH2 P25021 1/20 0.37
ADRA1D P25100 1/20 0.37
HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5773532 0.91 POLB (0.44) HTTSMN1; SMN2POLBHDAC4HDAC6
Trifluoroacetic Acid SCHEMBL5776847 0.90 MDM2 (0.39) HTTGFERDPP8DPP7CACNA1F
Trifluoroacetic Acid SCHEMBL5772964 0.89 TSHR (0.45) GFERDPP8DPP7CACNA1FHTR1A
Trifluoroacetic Acid SCHEMBL5777433 0.89 GFER (0.53) POLBGFERMAPTLMNAHPGD
Trifluoroacetic Acid SCHEMBL5772610 0.87 GFER (0.53) POLBGFERMAPTLMNAKMT2A
Trifluoroacetic Acid SCHEMBL5771806 0.87 POLB (0.47) POLBHDAC4HDAC6DPP8DPP7
Trifluoroacetic Acid SCHEMBL5776822 0.86 DPP8 (0.50) HTTGFERDPP8DPP7MAPT
Trifluoroacetic Acid SCHEMBL5776691 0.86 GRM5 (0.48) HTTSMN1; SMN2POLBGFERHTR1A
Trifluoroacetic Acid SCHEMBL5770006 0.85 KDM4E (0.39) HTTSMN1; SMN2DPP8DPP7CACNA1F
Trifluoroacetic Acid SCHEMBL5770044 0.85 RXFP1 (0.49) SMN1; SMN2POLBGFERMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR HTT 4375/4885SMN1; SMN2 3383/4885POLB 3996/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 HTT 3773/4885SMN1; SMN2 2449/4885POLB 3909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.